Home > Press > New PCR reagent kit accelerates next-generation sequencing
Abstract:
Available exclusively in the UK from Cambio, the new HaloPlex™ Target Enrichment Kit revolutionises next-generation sequencing, reducing costs and saving up to 80 per cent in sample preparation time compared to many other kits.
HaloPlex Target Enrichment Kit introduces a dramatically improved PCR technology that enables millions of PCR reactions in a single tube. Following fragmentation using specifically selected restriction endonucleases, and denaturing of the DNA sample, a Selector Probe library is added. Each probe, designed to hybridize to both ends of a targeted DNA restriction fragment, guides the targeted fragments to form circular DNA molecules. Only circular DNA targets are amplified, ready for sequencing using any next-generation procedure, and results are highly reproducible.
According to Dr Naeem Ahmed, Cambio's technical support specialist, ‘This new Halo Genomics kit provides a "lab-in-a-tube" solution which greatly simplifies PCR workflow, with no need for expensive instrumentation or automation. With next-generation nano scale PCR, reactions are parallelised at the molecular level so that no separate time-consuming library preparation stage is required. For a project targeting 100 genes in 1000 samples, HaloPlex Target Enrichment Kit reduces the total sample preparation time by as much as 80 per cent. Genomic regions of interest are enriched at the same time as the introduction of sample barcoding and sequence motifs.'
Current applications demonstrating the value of the HaloPlex PCR reagent kit for high performance targeted resequencing include studies of candidate genes involved in rare inherited diseases, pathway sequencing in matched tumour and normal samples, and clinical sequencing for BRCA gene assays.
####
About Cambio
Established in 1985, Cambio is a privately-held UK company with an excellent reputation for the supply of high quality molecular biology reagents and consumables. To meet the needs of a growing and diversifying market, advanced Molecular Biology products are continually added to the company’s extensive portfolio. This wide choice of research tools sourced from a global network of leading manufacturers is complemented by Cambio’s commitment to world-class technical support and customer service.
As a result, the company has built successful long-term customer relationships with scientific research laboratories within universities, large pharma and biotech companies, government agencies, agricultural organisations and environmental facilities. Based near Cambridge, UK, Cambio is ISO9001:2008 registered.
For more information, please click here
Contacts:
For sales and technical information please contact:
Cambio Ltd
The Irwin Centre, Scotland Road
Dry Drayton, Cambridge, CB23 8AR
Tel: 01954 210200
Fax: 01954 210300
E-mail:
Copyright © Cambio
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||